Qingdao NovelBeam Technology Co Ltd
SSE:688677
Qingdao NovelBeam Technology Co Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
25.73
47.59
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Qingdao NovelBeam Technology Co Ltd hold over its rivals?
What risks and challenges
does Qingdao NovelBeam Technology Co Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Qingdao NovelBeam Technology Co Ltd.
Provide an overview of the primary business activities
of Qingdao NovelBeam Technology Co Ltd.
What unique competitive advantages
does Qingdao NovelBeam Technology Co Ltd hold over its rivals?
What risks and challenges
does Qingdao NovelBeam Technology Co Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Qingdao NovelBeam Technology Co Ltd.
Provide P/S
for Qingdao NovelBeam Technology Co Ltd.
Provide P/E
for Qingdao NovelBeam Technology Co Ltd.
Provide P/OCF
for Qingdao NovelBeam Technology Co Ltd.
Provide P/FCFE
for Qingdao NovelBeam Technology Co Ltd.
Provide P/B
for Qingdao NovelBeam Technology Co Ltd.
Provide EV/S
for Qingdao NovelBeam Technology Co Ltd.
Provide EV/GP
for Qingdao NovelBeam Technology Co Ltd.
Provide EV/EBITDA
for Qingdao NovelBeam Technology Co Ltd.
Provide EV/EBIT
for Qingdao NovelBeam Technology Co Ltd.
Provide EV/OCF
for Qingdao NovelBeam Technology Co Ltd.
Provide EV/FCFF
for Qingdao NovelBeam Technology Co Ltd.
Provide EV/IC
for Qingdao NovelBeam Technology Co Ltd.
Show me price targets
for Qingdao NovelBeam Technology Co Ltd made by professional analysts.
What are the Revenue projections
for Qingdao NovelBeam Technology Co Ltd?
How accurate were the past Revenue estimates
for Qingdao NovelBeam Technology Co Ltd?
What are the Net Income projections
for Qingdao NovelBeam Technology Co Ltd?
How accurate were the past Net Income estimates
for Qingdao NovelBeam Technology Co Ltd?
What are the EPS projections
for Qingdao NovelBeam Technology Co Ltd?
How accurate were the past EPS estimates
for Qingdao NovelBeam Technology Co Ltd?
What are the EBIT projections
for Qingdao NovelBeam Technology Co Ltd?
How accurate were the past EBIT estimates
for Qingdao NovelBeam Technology Co Ltd?
Compare the revenue forecasts
for Qingdao NovelBeam Technology Co Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Qingdao NovelBeam Technology Co Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Qingdao NovelBeam Technology Co Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of Qingdao NovelBeam Technology Co Ltd compared to its peers.
Compare the P/E ratios
of Qingdao NovelBeam Technology Co Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing Qingdao NovelBeam Technology Co Ltd with its peers.
Analyze the financial leverage
of Qingdao NovelBeam Technology Co Ltd compared to its main competitors.
Show all profitability ratios
for Qingdao NovelBeam Technology Co Ltd.
Provide ROE
for Qingdao NovelBeam Technology Co Ltd.
Provide ROA
for Qingdao NovelBeam Technology Co Ltd.
Provide ROIC
for Qingdao NovelBeam Technology Co Ltd.
Provide ROCE
for Qingdao NovelBeam Technology Co Ltd.
Provide Gross Margin
for Qingdao NovelBeam Technology Co Ltd.
Provide Operating Margin
for Qingdao NovelBeam Technology Co Ltd.
Provide Net Margin
for Qingdao NovelBeam Technology Co Ltd.
Provide FCF Margin
for Qingdao NovelBeam Technology Co Ltd.
Show all solvency ratios
for Qingdao NovelBeam Technology Co Ltd.
Provide D/E Ratio
for Qingdao NovelBeam Technology Co Ltd.
Provide D/A Ratio
for Qingdao NovelBeam Technology Co Ltd.
Provide Interest Coverage Ratio
for Qingdao NovelBeam Technology Co Ltd.
Provide Altman Z-Score Ratio
for Qingdao NovelBeam Technology Co Ltd.
Provide Quick Ratio
for Qingdao NovelBeam Technology Co Ltd.
Provide Current Ratio
for Qingdao NovelBeam Technology Co Ltd.
Provide Cash Ratio
for Qingdao NovelBeam Technology Co Ltd.
What is the historical Revenue growth
over the last 5 years for Qingdao NovelBeam Technology Co Ltd?
What is the historical Net Income growth
over the last 5 years for Qingdao NovelBeam Technology Co Ltd?
What is the current Free Cash Flow
of Qingdao NovelBeam Technology Co Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for Qingdao NovelBeam Technology Co Ltd.
Qingdao NovelBeam Technology Co Ltd's latest stock split occurred on Jun 14, 2023
The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.
Before the split, Qingdao NovelBeam Technology Co Ltd traded at 78.6001 per share. Afterward, the share price was about 57.91.
The adjusted shares began trading on Jun 14, 2023. This was the only stock split in Qingdao NovelBeam Technology Co Ltd's history.
Global
Stock Splits Monitor
Qingdao NovelBeam Technology Co Ltd
Glance View
Qingdao NovelBeam Technology Co., Ltd. engages in the research and development of optics technology, the manufacture of optical instruments, and the provision of design solutions for medical, life science, laser, and micro-display projection applications. The company is headquartered in Qingdao, Shandong and currently employs 854 full-time employees. The company went IPO on 2021-02-26. Its main products of medical endoscope equipment include fluorescent endoscopes, fluorescent camera adapters/adaptive lenses, fluorescent light source modules and white light source modules. Its medical endoscopic equipment products are mainly used in abdominal endoscopic surgery such as liver and gallbladder and gastrointestinal surgery. Its optical products mainly include medical optical products, industrial and laser optical products, and biometric products. Among them, the biometric products include fingerprint devices, palmprint devices and related accessories. In addition, the Company also provides technical services and house leasing services. The firm distributes its products both in the domestic market and to overseas markets.